PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • They may also consider questions such as whether a proposed study for an experimental drug should be conducted or whether the safety and effectiveness information submitted for a new drug are adequate for marketing approval.For additional information about FDA advisory committee meetings, call 800-741-8138.
http://www.w3.org/ns/prov#wasQuotedFrom
  • fda.gov